Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sechter

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Presse Medicale (Paris, France : 1983)|June 22, 1985
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol]H Loo, B Scatton, M F Poirier, et al.
European Journal of Clinical Pharmacology|January 19, 2000
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypesP Vandel, E Haffen, S Vandel, et al.
Acta Psychiatrica Scandinavica|February 1, 1990
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patientsJ M Vanelle, M F Poirier, C Benkelfat, et al.
Clinical Neuropharmacology|January 1, 1992
Metabolic interaction between tricyclic antidepressant and fluvoxamine and fluoxetine, a pharmacogenetic approachG Bertschy, S Vandel, T Francois, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?E Haffen, P Vandel, G Paintaud, et al.
Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.
European Journal of Pharmacology|November 27, 1984
[3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatmentM F Poirier, H Loo, C Benkelfat, et al.
Journal of Affective Disorders|March 1, 2002
Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN studyH S Akiskal, E G Hantouche, M L Bourgeois, et al.
Journal of Affective Disorders|March 1, 2002
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN studyE G Hantouche, J P Allilaire, M L Bourgeois, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Presse Medicale (Paris, France : 1983)|June 22, 1985
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol]H Loo, B Scatton, M F Poirier, et al.
European Journal of Clinical Pharmacology|January 19, 2000
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypesP Vandel, E Haffen, S Vandel, et al.
Acta Psychiatrica Scandinavica|February 1, 1990
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patientsJ M Vanelle, M F Poirier, C Benkelfat, et al.
Clinical Neuropharmacology|January 1, 1992
Metabolic interaction between tricyclic antidepressant and fluvoxamine and fluoxetine, a pharmacogenetic approachG Bertschy, S Vandel, T Francois, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?E Haffen, P Vandel, G Paintaud, et al.
Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.
European Journal of Pharmacology|November 27, 1984
[3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatmentM F Poirier, H Loo, C Benkelfat, et al.
Journal of Affective Disorders|March 1, 2002
Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN studyH S Akiskal, E G Hantouche, M L Bourgeois, et al.
Journal of Affective Disorders|March 1, 2002
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN studyE G Hantouche, J P Allilaire, M L Bourgeois, et al.
Pageof 9